checkAd

     142  0 Kommentare Kane Biotech Announces New Chairman - Seite 3

    COVID-19 Pandemic

    Since December 31, 2019, the COVID-19 outbreak of the novel strain of coronavirus, SARS- CoV-2, has resulted in a widespread health crisis that has affected economies and financial markets around the world resulting in an economic downturn. The effects of this pandemic on the Company may include decreased customer demand, interruptions to supply chains, manufacturing activities and research and development programs and increased government regulations or interventions. The duration and impact of the COVID-19 outbreak is unknown at this time and it is not possible to reliably estimate the length and severity of these developments nor the impact of these developments on the financial results and condition of the Company in future periods.

    Lesen Sie auch

    Source: Kane Biotech Inc.


    Seite 3 von 3




    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Kane Biotech Announces New Chairman - Seite 3 WINNIPEG, Manitoba, Feb. 24, 2021 (GLOBE NEWSWIRE) - Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announced today current Board member Mark Nawacki will take over as Chairman of the Board, and Philip Renaud will …